These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26213846)

  • 41. Long non-coding RNA LUCAT1/miR-5582-3p/TCF7L2 axis regulates breast cancer stemness via Wnt/β-catenin pathway.
    Zheng A; Song X; Zhang L; Zhao L; Mao X; Wei M; Jin F
    J Exp Clin Cancer Res; 2019 Jul; 38(1):305. PubMed ID: 31300015
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Silencing of WISP3 suppresses gastric cancer cell proliferation and metastasis and inhibits Wnt/β-catenin signaling.
    Fang F; Zhao WY; Li RK; Yang XM; Li J; Ao JP; Jiang SH; Kong FZ; Tu L; Zhuang C; Qin WX; He P; Zhang WM; Cao H; Zhang ZG
    Int J Clin Exp Pathol; 2014; 7(10):6447-61. PubMed ID: 25400723
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The long noncoding RNA HOTTIP promotes breast cancer cell migration, invasiveness, and epithelial-mesenchymal transition via the Wnt-β-catenin signaling pathway.
    Han S; Jin X; Liu Z; Xing F; Han Y; Yu X; He G; Qiu F
    Biochem Cell Biol; 2019 Oct; 97(5):655-664. PubMed ID: 30676763
    [TBL] [Abstract][Full Text] [Related]  

  • 44. LHX6 inhibits breast cancer cell proliferation and invasion via repression of the Wnt/β-catenin signaling pathway.
    Hu Z; Xie L
    Mol Med Rep; 2015 Sep; 12(3):4634-4639. PubMed ID: 26129710
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Suppression of the proliferation and invasion of breast cancer cells by ST7L occurs through inhibition of activation of Wnt/GSK-3β/β-catenin signalling.
    Wang H; Sun L; Jiang J; Yu S; Zhou Q
    Clin Exp Pharmacol Physiol; 2020 Jan; 47(1):119-126. PubMed ID: 31429477
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Wnt signaling pathway in invasive ductal carcinoma of the breast: relationship between beta-catenin, dishevelled and cyclin D1 expression.
    Prasad CP; Gupta SD; Rath G; Ralhan R
    Oncology; 2007; 73(1-2):112-7. PubMed ID: 18337623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MicroRNA-216a suppresses the proliferation and migration of human breast cancer cells via the Wnt/β-catenin signaling pathway.
    Xie Q; Wang S; Zhao Y; Zhang Z; Qin C; Yang X
    Oncol Rep; 2019 May; 41(5):2647-2656. PubMed ID: 30864744
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A novel oncogene TRIM63 promotes cell proliferation and migration via activating Wnt/β-catenin signaling pathway in breast cancer.
    Li K; Pan W; Ma Y; Xu X; Gao Y; He Y; Wei L; Zhang J
    Pathol Res Pract; 2019 Oct; 215(10):152573. PubMed ID: 31399258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-603 promotes glioma cell growth via Wnt/β-catenin pathway by inhibiting WIF1 and CTNNBIP1.
    Guo M; Zhang X; Wang G; Sun J; Jiang Z; Khadarian K; Yu S; Zhao Y; Xie C; Zhang K; Zhu M; Shen H; Lin Z; Jiang C; Shen J; Zheng Y
    Cancer Lett; 2015 Apr; 360(1):76-86. PubMed ID: 25681036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LMO2 attenuates tumor growth by targeting the Wnt signaling pathway in breast and colorectal cancer.
    Liu Y; Huang D; Wang Z; Wu C; Zhang Z; Wang D; Li Z; Zhu T; Yang S; Sun W
    Sci Rep; 2016 Oct; 6():36050. PubMed ID: 27779255
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H; Murao K; Dobashi H; Bhuyan MM; Cao X; Kontani K; Niki S; Murazawa C; Nakajima H; Kohno N; Yamashita H; Iwase H; Hayashi S; Ishida T; Yamauchi A
    Breast Cancer Res Treat; 2010 Jul; 122(2):395-407. PubMed ID: 19847644
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Upregulated IQUB promotes cell proliferation and migration via activating Akt/GSK3β/β-catenin signaling pathway in breast cancer.
    Li K; Ma YB; Zhang Z; Tian YH; Xu XL; He YQ; Xu L; Gao Y; Pan WT; Song WJ; He X; Wei L
    Cancer Med; 2018 Aug; 7(8):3875-3888. PubMed ID: 29968965
    [TBL] [Abstract][Full Text] [Related]  

  • 53. ZFP57 suppress proliferation of breast cancer cells through down-regulation of MEST-mediated Wnt/β-catenin signalling pathway.
    Chen L; Wu X; Xie H; Yao N; Xia Y; Ma G; Qian M; Ge H; Cui Y; Huang Y; Wang S; Zheng M
    Cell Death Dis; 2019 Feb; 10(3):169. PubMed ID: 30787268
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A novel cell-penetrating peptide suppresses breast tumorigenesis by inhibiting β-catenin/LEF-1 signaling.
    Hsieh TH; Hsu CY; Tsai CF; Chiu CC; Liang SS; Wang TN; Kuo PL; Long CY; Tsai EM
    Sci Rep; 2016 Jan; 6():19156. PubMed ID: 26750754
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Aberrantly upregulated TRAP1 is required for tumorigenesis of breast cancer.
    Zhang B; Wang J; Huang Z; Wei P; Liu Y; Hao J; Zhao L; Zhang F; Tu Y; Wei T
    Oncotarget; 2015 Dec; 6(42):44495-508. PubMed ID: 26517089
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Therapeutic targeting of casein kinase 1δ in breast cancer.
    Rosenberg LH; Lafitte M; Quereda V; Grant W; Chen W; Bibian M; Noguchi Y; Fallahi M; Yang C; Chang JC; Roush WR; Cleveland JL; Duckett DR
    Sci Transl Med; 2015 Dec; 7(318):318ra202. PubMed ID: 26676609
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Nectin-4 is a breast cancer stem cell marker that induces WNT/β-catenin signaling via Pi3k/Akt axis.
    Siddharth S; Goutam K; Das S; Nayak A; Nayak D; Sethy C; Wyatt MD; Kundu CN
    Int J Biochem Cell Biol; 2017 Aug; 89():85-94. PubMed ID: 28600142
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TGF-β-induced DACT1 biomolecular condensates repress Wnt signalling to promote bone metastasis.
    Esposito M; Fang C; Cook KC; Park N; Wei Y; Spadazzi C; Bracha D; Gunaratna RT; Laevsky G; DeCoste CJ; Slabodkin H; Brangwynne CP; Cristea IM; Kang Y
    Nat Cell Biol; 2021 Mar; 23(3):257-267. PubMed ID: 33723425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Sohlh2 inhibits breast cancer cell proliferation by suppressing Wnt/β-catenin signaling pathway.
    Zhang X; Liu R; Zhao N; Ji S; Hao C; Cui W; Zhang R; Hao J
    Mol Carcinog; 2019 Jun; 58(6):1008-1018. PubMed ID: 30720232
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Twist1 promotes breast cancer invasion and metastasis by silencing Foxa1 expression.
    Xu Y; Qin L; Sun T; Wu H; He T; Yang Z; Mo Q; Liao L; Xu J
    Oncogene; 2017 Feb; 36(8):1157-1166. PubMed ID: 27524420
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.